Aarkstore - Regado Biosciences, Inc. - Product Pipeline Review - 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Regado Biosciences, Inc. - Product Pipeline Review - 2014

Description:

"Regado Biosciences, Inc. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. – PowerPoint PPT presentation

Number of Views:22

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Regado Biosciences, Inc. - Product Pipeline Review - 2014


1
Regado Biosciences, Inc. - Product Pipeline
Review - 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/63687/regado-biosciences-inc-product-pipeline-re
    view

2
Regado Biosciences, Inc. - Product Pipeline
Review - 2014
3
Summary
  • Global Markets Directs, Regado Biosciences,
    Inc. - Product Pipeline Review - 2014, provides
    an overview of the Regado Biosciences, Inc.s
    pharmaceutical research and development
    focus.  This report provides comprehensive
    information on the current therapeutic
    developmental pipeline of Regado Biosciences,
    Inc.s, complete with comparative analysis at
    various stages, therapeutics assessment by drug
    target, mechanism of action (MoA), route of
    administration (RoA) and molecule type. It also
    reviews latest updates, and featured news and
    press releases, along with special features on
    late-stage and discontinued projects.  "Regado
    Biosciences, Inc. - Product Pipeline Review -
    2014"report features investigational drugs from
    across globe covering over 20 therapy areas and
    nearly 3,000 indications. The report is built
    using data and information sourced from Global
    Markets Directs proprietary databases,
    Company/University websites, SEC filings,
    investor presentations and featured press
    releases from company/university sites and
    industry-specific third party sources, put
    together by Global Markets Directs team.

4
Summary
  • Drug profiles/records featured in the report
    undergoes periodic updation following a stringent
    set of processes that ensures that all the
    profiles are updated with the latest set of
    information. Additionally, processes including
    live news deals tracking, browser based
    alert-box and clinical trials registries tracking
    ensure that the most recent developments are
    captured on a real time basis.  The report
    enhances decision making capabilities and help to
    create effective counter strategies to gain
    competitive advantage. It strengthens RD
    pipelines by identifying new targets and MOAs to
    produce first-in-class and best-in-class
    products.  Note Certain sections in the
    report may be removed or altered based on the
    availability and relevance of data for the
    indicated disease. 

5
Scope
  • - The report provides brief overview of Regado
    Biosciences, Inc. including business description,
    key information and facts, and its locations and
    subsidiaries - The report reviews current
    pipeline of Regado Biosciences, Inc.s human
    therapeutic division and enlists all their major
    and minor projects - The report features product
    description and descriptive mechanism of action
    for key pipeline products along with the
    products developmental history and major
    milestones  - Special feature on out-licensed
    and partnered product portfolio - The report
    summarizes all the dormant and discontinued
    pipeline projects - Latest company statement  -
    Latest news and deals relating to the Regado
    Biosciences, Inc.s pipeline products

6
Reasons to buy
  • - Evaluate Regado Biosciences, Inc.s strategic
    position with total access to detailed
    information on its product pipeline - Assess the
    growth potential of Regado Biosciences, Inc. in
    its therapy areas of focus - Identify new drug
    targets and therapeutic classes in the Regado
    Biosciences, Inc.s RD portfolio and develop key
    strategic initiatives to reinforce pipeline in
    those areas - Exploit in-licensing opportunities
    by identifying windows of opportunity to fill
    portfolio gaps - Develop strategic initiatives
    by understanding the focus areas of Regado
    Biosciences, Inc. and exploit collaboration and
    partnership opportunities - Identify emerging
    players with potentially strong product portfolio
    and create effective counter-strategies to gain
    competitive advantage - Plan mergers and
    acquisitions effectively by identifying the most
    promising pipeline of Regado Biosciences, Inc. -
    Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope

7
Table of Content
List of Tables 3List of Figures 3Regado
Biosciences, Inc. Snapshot 4Regado Biosciences,
Inc. Overview 4Key Information 4Key Facts
4Regado Biosciences, Inc. - Research and
Development Overview 5Key Therapeutic Areas
5Regado Biosciences, Inc. - Pipeline Review
7Pipeline Products by Stage of Development
7Pipeline Products - Monotherapy 8Regado
Biosciences, Inc. - Pipeline Products Glance
9Regado Biosciences, Inc. - Clinical Stage
Pipeline Products 9Phase I Products/Combination
Treatment Modalities 9
8
Table of Content
Regado Biosciences, Inc. - Early Stage Pipeline
Products 10Preclinical Products/Combination
Treatment Modalities 10Discovery
Products/Combination Treatment Modalities
11Regado Biosciences, Inc. - Drug Profiles
12REG-2 12Product Description 12Mechanism of
Action 12RD Progress 12REG-3 14Product
Description 14Mechanism of Action 14RD
Progress 14Aptamers for Cardiovascular Diseases
15Product Description 15
9
List Of Tables
  • Regado Biosciences, Inc., Key Information
    4Regado Biosciences, Inc., Key Facts 4Regado
    Biosciences, Inc. - Pipeline by Indication, 2014
    6Regado Biosciences, Inc. - Pipeline by Stage of
    Development, 2014 7Regado Biosciences, Inc. -
    Monotherapy Products in Pipeline, 2014 8Regado
    Biosciences, Inc. - Phase I, 2014 9Regado
    Biosciences, Inc. - Preclinical, 2014 10Regado
    Biosciences, Inc. - Discovery, 2014 11Regado
    Biosciences, Inc. - Pipeline by Target, 2014
    16Regado Biosciences, Inc. - Pipeline by Route
    of Administration, 2014 17Regado Biosciences,
    Inc. - Pipeline by Molecule Type, 2014 18Regado
    Biosciences, Inc. - Pipeline Products by
    Mechanism of Action, 2014 19Regado Biosciences,
    Inc. - Recent Pipeline Updates, 2014 20Regado
    Biosciences, Inc. - Discontinued Pipeline
    Products, 2014 21Regado Biosciences, Inc., Other
    Locations 22

10
List of Figures
  • Regado Biosciences, Inc. - Pipeline by Top 10
    Indication, 2014 6Regado Biosciences, Inc. -
    Pipeline by Stage of Development, 2014 7Regado
    Biosciences, Inc. - Monotherapy Products in
    Pipeline, 2014 8Regado Biosciences, Inc. -
    Pipeline by Top 10 Target, 2014 16Regado
    Biosciences, Inc. - Pipeline by Top 10 Route of
    Administration, 2014 17Regado Biosciences, Inc.
    - Pipeline by Top 10 Molecule Type, 2014
    18Regado Biosciences, Inc. - Pipeline Products
    by Top 10 Mechanism of Action, 2014 19  

11
Related Reports
  • Global Neurosurgery Market 2015-2019
  • Active Pharmaceutical Ingredients (API) Market in
    India 2015-2019
  • BrainStorm Cell Therapeutics Inc. (BCLI) -
    Financial and Strategic SWOT Analysis Review
  • Ampio Pharmaceuticals, Inc. (AMPE) - Financial
    and Strategic SWOT Analysis Review
  • MiMedx Group, Inc (MDXG) - Financial and
    Strategic SWOT Analysis Review

12
Related Reports
  • Threshold Pharmaceuticals, Inc. (THLD) -
    Financial and Strategic SWOT Analysis Review
  • MEI Pharma, Inc. (MEIP) - Financial and Strategic
    SWOT Analysis Review
  • Titan Pharmaceuticals, Inc. (TTNP) - Financial
    and Strategic SWOT Analysis Review
  • RedHill Biopharma Ltd. (RDHL) - Financial and
    Strategic SWOT Analysis Review
  • Pharmaceuticals Healthcare Market Research
    Reports

13
  • Regado Biosciences, Inc. - Product Pipeline
    Review - 2014 Published Oct 2014 24 Pages
  • "Regado Biosciences, Inc. - Product Pipeline
    Review - 2014"report features investigational
    drugs from across globe covering over 20 therapy
    areas and nearly 3,000 indications.
    Price

Format Price
PDF 1500
Site Licence 3000
Enterprise Wide Licence 4500
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com